Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Debbie Saslow"'
Autor:
Adair K. Minihan, Priti Bandi, Jessica Star, Marcie Fisher-Borne, Debbie Saslow, Ahmedin Jemal
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Recent guidelines from the American Cancer Society stress HPV vaccination series initiation at the youngest opportunity, i.e., age 9 years. There are limited data on the association between initiating HPV vaccination at ages 9–10 years and up-to-da
Externí odkaz:
https://doaj.org/article/1d3f5571768e4ff89222286439238760
Autor:
Robert A. Bednarczyk, Noel T. Brewer, Melissa B. Gilkey, Sherri Zorn, Rebecca B. Perkins, Kristin Oliver, Debbie Saslow
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
The Advisory Committee on Immunization Practices (ACIP) has recommended human papillomavirus (HPV) vaccination for adolescents in the United States since 2006. Though recommended at a similar time to the routine recommendations for adolescent tetanus
Externí odkaz:
https://doaj.org/article/04352da011d94c789fd811d763ef58e1
Autor:
Erika L. Thompson, Ellen M. Daley, Tricia Washburn, Kim Salisbury-Keith, Debbie Saslow, Holly B. Fontenot, Gregory D. Zimet
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 7, Pp 1975-1979 (2021)
Human papillomavirus (HPV) vaccination can prevent six types of HPV-related cancers, and approximately, 54.2% of adolescents are up-to-date with the HPV vaccine in the United States. While moderate success has been achieved with provider- and parent-
Externí odkaz:
https://doaj.org/article/9f0e53c11d3f4897bfa6ed88db3c686c
Autor:
Didem, Egemen, Rebecca B, Perkins, Megan A, Clarke, Richard, Guido, Warner, Huh, Mona, Saraiya, Debbie, Saslow, Robert, Smith, Elizabeth R, Unger, Francisco, Garcia, Nicolas, Wentzensen, Li C, Cheung
Publikováno v:
J Low Genit Tract Dis
In the 2019 ASCCP Risk-Based Management Consensus Guidelines, clinical management decisions are based on immediate and 5-year cervical intraepithelial neoplasia (CIN) 3+ risk estimates. However, data for technologies other than human papillomavirus t
Autor:
Irene O. Aninye, J. Michael Berry-Lawhorn, Paul Blumenthal, Tamika Felder, Naomi Jay, Janette Merrill, Jenna B. Messman, Sarah Nielsen, Rebecca Perkins, Tami Rowen, Debbie Saslow, Connie Liu Trimble, Karen Smith-McCune
Publikováno v:
Journal of Women's Health
Human papillomavirus (HPV) infections cause more than 35,900 cancers annually in the United States. Although cervical cancer is the most prevalent HPV-related malignancy in women, the virus is also responsible for a significant percentage of anal, va
Publikováno v:
Annals of internal medicine. 175(7)
Autor:
Rebecca Landy, Christopher Mathews, Michael Robertson, Charles L. Wiggins, Yolanda J. McDonald, Daniel W. Goldberg, Isabel C. Scarinci, Jack Cuzick, Peter D. Sasieni, Cosette M. Wheeler, Nancy E. Joste, Walter Kinney, Ruth M. McDonald, Alan Waxman, Steven Jenison, Philip E. Castle, Vicki Benard, Debbie Saslow, Jane J. Kim, Mark H. Stoler, Giovanna Rossi, Kevin English
Publikováno v:
Gynecologic Oncology
Objective Despite widespread cervical screening, an estimated 13,800 women will be diagnosed with cervical cancer in the United States in 2020. To inform improvements, the screening histories of women diagnosed with cervical cancer in New Mexico were
Autor:
Ruth Etzioni, Robert A. Smith, Abbe Herzig, Stacey A. Fedewa, Timothy R. Church, Richard C. Wender, Kimberly S. Andrews, Andrew M.D. Wolf, Jane J. Kim, Carol DeSantis, Debbie Saslow, Kevin C. Oeffinger, Carmen Guerra, Ya Chen Tina Shih, Elizabeth T. H. Fontham, Louise C. Walter, Christopher R. Flowers, Deana Manassaram-Baptiste
Publikováno v:
CA: A Cancer Journal for Clinicians. 70:321-346
The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV testi
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation
Autor:
Robert A. Smith, Elizabeth T. H. Fontham, Kimberly S. Andrews, Debbie Saslow, Deana Manassaram-Baptiste
Publikováno v:
CA: A Cancer Journal for Clinicians. 70:274-280
The American Cancer Society (ACS) presents an adaptation of the current Advisory Committee on Immunization Practices recommendations for human papillomavirus (HPV) vaccination. The ACS recommends routine HPV vaccination between ages 9 and 12 years to
Autor:
Jack Cuzick, Ruofei Du, Rachael Adcock, Walter Kinney, Nancy Joste, Ruth M. McDonald, Kevin English, Salina M. Torres, Debbie Saslow, Cosette M. Wheeler, Nancy E. Joste, Charles Wiggins, Michael Robertson, Ruth McDonald, Alan Waxman, Steven Jenison, Philip E. Castle, Vicki Benard, Stephanie C. Melkonian, Jean Howe, Jane J. Kim, Mark H. Stoler, Rebecca B. Perkins, Janice L. Gonzales, Salina Torres, Giovanna Rossi
Publikováno v:
Gynecol Oncol
Objectives Human papillomavirus (HPV) testing for cervical screening has been shown to increase the yield of precancerous disease and reduce the incidence of cervical cancer more than cytology alone. Here we document the state-wide uptake of co-testi